CRSP vs CVX · rev $11.6M vs P/E 17, rev $118.66B
Crispr Therapeutics AG (CRSP) versus Chevron Corp (CVX) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Michael K. Wirth.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
CRSP currently screens at market cap $5.42B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Not investment advice. Open the CRSP and CVX stock pages for the full models.
Not investment advice.